Clinical Trial

SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluation of the Safety and Efficacy of SHR2554 as Maintenance Therapy after first-line systemic treatment in patients with peripheral T-cell lymphoma
Trial Details
NCT Number NCT07347288
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions PTCL
Enrollment 30 participants
Start Date 2026-02
Primary Completion 2029-02 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-16